Compugen (CGEN) EBT Margin Growth (1y) (2010 - 2026)
Compugen (CGEN) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Compugen | 221.26 Mn | 129.51 Mn | 352,000.00 | 3,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,916.00 |
| Dec 31, 2025 | 49,999.00 |
| Sep 30, 2025 | -40,069.00 |
| Jun 30, 2025 | -147,479.00 |
| Mar 31, 2025 | 2,919.00 |
| Dec 31, 2024 | -47,151.00 |
| Dec 31, 2023 | 9,640.00 |
| Dec 31, 2016 | -1.60 Mn |
| Sep 30, 2016 | -817,161.00 |
| Jun 30, 2016 | 171,985.00 |
| Mar 31, 2016 | -830,635.00 |
| Dec 31, 2015 | 1,705.00 |
| Sep 30, 2015 | -263,008.00 |
| Jun 30, 2015 | -293,789.00 |
| Mar 31, 2015 | -107,713.00 |
| Dec 31, 2014 | 12,748.00 |
| Sep 30, 2014 | -2,554.00 |
| Jun 30, 2014 | 1.37 Mn |
| Mar 31, 2014 | 229,169.00 |
| Dec 31, 2013 | 386,418.00 |